Stay updated on Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record itself still displays a 403 error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error with a basic header/footer, replacing the previous detailed study content and links. This means the study record content is no longer accessible at this URL.SummaryDifference17%

- Check66 days agoChange DetectedA new safety outcome, 'Number of Participants With Grade 3+ Adverse Events,' was added to the study's outcomes, and the previous endpoint 'Incidence of Adverse Events' was removed, reflecting an update to how adverse events are reported in the study record.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.